https://www.thebodypro.com/article/merck-acquires-cmx157-and-efda-and-starts-phase-2-
HIV Treatments in Development

Merck Acquires CMX157 and EFdA and Starts Phase 2 Study for New NNRTI

    Simon Collins

    HIV i-Base

    HIV i-Base